Tyme Technologies Liabilities 2024

Tyme Technologies Aktienanalyse

What does Tyme Technologies do?

Tyme Technologies Inc is a biopharmaceutical company specializing in the development of cancer drugs. The company was founded in 2011 by Steve Hoffman in New York City. Tyme Technologies Inc aims to provide a solution for the urgent need for new cancer drugs. The business model of Tyme Technologies Inc focuses on research and development of therapies for various types of cancer. The company takes an innovative approach by targeting the metabolism of tumor cells to combat them. The goal is to provide personalized medicine to cancer patients, tailored to their specific cancer types and with fewer side effects. Tyme Technologies has achieved success in various areas and is actively working on establishing cancer treatment products. The company engages in its own research as well as collaborations with other companies and institutions. One of Tyme Technologies' areas of focus is the research and development of drugs for triple-negative breast cancer. This type of cancer is known to be very aggressive and spreads quickly. Tyme Technologies has developed a promising drug called SM-88, which aims to disrupt the metabolic processes in cancer cells, causing them to die. Another significant project of Tyme Technologies is the research and development of drugs for glioma, a particularly aggressive brain tumor for which there are currently no effective therapies. The company has successfully tested the drug SM-88 in a phase II study for this purpose. Tyme Technologies has also focused on cancer treatment in children. The company has conducted clinical trials for the treatment of neuroblastoma and osteosarcoma, both of which are rare and particularly aggressive types of cancer that mainly affect children. In terms of product offerings, Tyme Technologies has introduced various products to the market. One of them is the NLC-001 immunotherapy program, which focuses on activating the body's immune response against cancer cells. The company has also developed a test procedure for personalizing therapy in patients with triple-negative breast cancer, based on the patient's genetic profile. In summary, Tyme Technologies Inc is an emerging biopharmaceutical company specializing in the development of personalized therapies to combat various types of cancer. With its innovative technology, the company has already achieved significant success, particularly in the development of drugs for triple-negative breast cancer and brain tumors. The company continuously collaborates with other companies and institutions and invests in research and development of new cancer drugs in the long term. Tyme Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Tyme Technologies's Liabilities

Tyme Technologies's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Tyme Technologies's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Tyme Technologies's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Tyme Technologies's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Tyme Technologies’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Tyme Technologies stock

What is the level of liabilities of Tyme Technologies this year?

Tyme Technologies has a debt balance of 7.93 M USD this year.

What were the liabilities of Tyme Technologies compared to the previous year?

The liabilities of Tyme Technologies have increased by -6.33% dropped compared to the previous year.

What are the consequences of high debt for investors of Tyme Technologies?

High liabilities can pose a risk for investors of Tyme Technologies, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Tyme Technologies?

Low liabilities mean that Tyme Technologies has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Tyme Technologies affect the company?

An increase in liabilities of Tyme Technologies can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Tyme Technologies affect the company?

A decrease in the liabilities of Tyme Technologies can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Tyme Technologies?

Some factors that can influence the liabilities of Tyme Technologies include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Tyme Technologies so important for investors?

The liabilities of Tyme Technologies are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Tyme Technologies take to modify the liabilities?

To change its liabilities, Tyme Technologies can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Tyme Technologies pay?

Over the past 12 months, Tyme Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tyme Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Tyme Technologies?

The current dividend yield of Tyme Technologies is .

When does Tyme Technologies pay dividends?

Tyme Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tyme Technologies?

Tyme Technologies paid dividends every year for the past 0 years.

What is the dividend of Tyme Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tyme Technologies located?

Tyme Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tyme Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tyme Technologies from 12/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/30/2024.

When did Tyme Technologies pay the last dividend?

The last dividend was paid out on 12/30/2024.

What was the dividend of Tyme Technologies in the year 2023?

In the year 2023, Tyme Technologies distributed 0 USD as dividends.

In which currency does Tyme Technologies pay out the dividend?

The dividends of Tyme Technologies are distributed in USD.